10 hottest ISA shares, funds and trusts: week ended 31 January 2025

We reveal the 10 most-popular shares, funds and investment trusts added to ISAs on the interactive investor platform during the past week.

3rd February 2025 12:02

by Lee Wild from interactive investor

Share on

Investor studying chart on smartphone 600

We look at the investments ii customers have been buying within their ISAs during the previous week. The data includes only real-time trades, not regular investing instructions, and combines the use of both existing funds and new money.

Top 10 shares in ISAs

Company Name

Place change 

1

NVIDIA Corp (NASDAQ:NVDA)

Up 7

2

Rolls-Royce Holdings (LSE:RR.)

Up 1

3

Glencore (LSE:GLEN)

New

4

Microsoft Corp (NASDAQ:MSFT)

New

5

Tesla Inc (NASDAQ:TSLA)

New

6

ImmuPharma (LSE:IMM)

New

7

MicroStrategy Inc Class A (NASDAQ:MSTR)

Unchanged

8

Broadcom Inc (NASDAQ:AVGO)

New

9

Advanced Micro Devices Inc (NASDAQ:AMD)

New

10

Taylor Wimpey (LSE:TW.)

Down 6

It’s all change in this list of most-bought stocks in ISAs on the ii platform last week, with a new name at the top and six new entries.

NVIDIA Corp (NASDAQ:NVDA) shares generated the most buying activity in any week since June, and recorded the second-biggest volume of buy trades in ISAs on the ii platform since we started this column more than a year ago. That was enough to jump the chip giant seven places and knock Taylor Wimpey (LSE:TW.) off op spot.

A sudden realisation that American technology is not the only show in town triggered a broad sell-off in top US tech names, including Nvidia. It’s because DeepSeek, a new AI system developed in China, appears more advanced than existing AI, is open-source, so can be used by anyone for commercial purposes, and is said to be much cheaper than existing AI which American companies have spent tens of billions of dollars developing.

Nvidia lost around $600 billion dollars in value, with its share price crashing 18% from over $142 to a low of around $116. But investors bet the selling was overdone and piled in. Nvidia stock remained volatile, trading as high as $129 before ending the week at $120.

Of the six new entries, four of them are US companies. Microsoft Corp (NASDAQ:MSFT) hasn’t been in this list since the start of November but was the fourth most-bought stock in ISAs last week. It’s likely down to bargain hunting after the software giant’s second-quarter results beat expectations, but third-quarter forecasts were less than expected. Shares fell to prices rarely seen in the past five months.

Tesla Inc (NASDAQ:TSLA) is back in the list after a three-week absence following sales and earnings that missed Wall Street estimates. Shares were volatile but managed to finish Friday in the upper half of the week’s range.

Broadcom Inc (NASDAQ:AVGO) is another newbie, with interest triggered by DeepSeek losses. Advanced Micro Devices Inc (NASDAQ:AMD), which last made an appearance here over Christmas, suffered too, but some investors clearly believe the shares at a one-year low are attractive.

Elsewhere, Glencore (LSE:GLEN) made it into the top 10 for the first time since December as shares traded at levels not seen since September 2021. In the wake of news that merger discussions with Rio Tinto came to nothing, the mining company said full-year production was in line with guidance following an improvement in the second half. Annual results are due on 19 February.

Finally, ImmuPharma (LSE:IMM) makes its debut in the top 10 at number six. Shares in the £22 million AIM company have piqued interest among investors since early January when they were trading at just 1.2p. They were worth as much as 7.4p last week, forcing the company to issue a statement, repeating previous news about “ground-breaking advancements” in its research into autoimmune diseases. It also said “a number” of global biopharma companies were interested in its P140 research programme when it attended the JP Morgan and Biotech Showcase healthcare conferences earlier last month.

Top 10 funds and trusts in ISAs

Despite market turbulence around the success of a Chinese AI model from DeepSeek, which was rumoured to be built for just $6 million, tech funds remained popular last week.

Scottish Mortgage Ord (LSE:SMT) and L&G Global Technology Index I Acc held on to the top two spots, even as their values dropped about 5% each last Monday. They later recovered to trade around flat for the week. Polar Capital Technology Ord (LSE:PCT) also entered the list in fifth place as investors sought to buy the dip in tech valuations.

These three technology funds offer different ways of getting access to the fast-growing asset class. The biggest differentiator for Scottish Mortgage is its 50 private stocks (worth around 25% of the fund), while L&G takes a passive approach and Polar Capital actively selects stocks, with a focus on the largest names.

The other risers were Royal London Short Term Money Mkt Y Acc, Greencoat UK Wind (LSE:UKW), Fidelity Index World P Acc and HSBC FTSE All-World Index C Acc.

Royal London and Greencoat offer attractive income yields of around 5% and 8.5%, while the other two funds track global markets for just 0.12% and 0.13% in fees. 

Vanguard LifeStrategy 80% Equity, JPMorgan Global Growth & Income Ord (LSE:JGGI) and Vanguard U.S. Eq Idx £ Acc all dropped down the most-bought list, while Artemis US Smaller Companies and Assura fell off.

Funds and trusts section written by ii’s Sam Benstead.

These articles are provided for information purposes only.  Occasionally, an opinion about whether to buy or sell a specific investment may be provided by third parties.  The content is not intended to be a personal recommendation to buy or sell any financial instrument or product, or to adopt any investment strategy as it is not provided based on an assessment of your investing knowledge and experience, your financial situation or your investment objectives. The value of your investments, and the income derived from them, may go down as well as up. You may not get back all the money that you invest. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment adviser.

Full performance can be found on the company or index summary page on the interactive investor website. Simply click on the company's or index name highlighted in the article.

Please remember, investment value can go up or down and you could get back less than you invest. If you’re in any doubt about the suitability of a stocks & shares ISA, you should seek independent financial advice. The tax treatment of this product depends on your individual circumstances and may change in future. If you are uncertain about the tax treatment of the product you should contact HMRC or seek independent tax advice.

Related Categories

    FundsInvestment TrustsNorth AmericaGlobalISAsUK sharesEuropeBonds and giltsAIM & small cap sharesEmerging marketsEditors' picks

Get more news and expert articles direct to your inbox